248 related articles for article (PubMed ID: 38197196)
1. TACC3: a multi-functional protein promoting cancer cell survival and aggressiveness.
Saatci O; Sahin O
Cell Cycle; 2023; 22(23-24):2637-2655. PubMed ID: 38197196
[TBL] [Abstract][Full Text] [Related]
2. Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification.
Saatci O; Akbulut O; Cetin M; Sikirzhytski V; Uner M; Lengerli D; O'Quinn EC; Romeo MJ; Caliskan B; Banoglu E; Aksoy S; Uner A; Sahin O
Cell Death Differ; 2023 May; 30(5):1305-1319. PubMed ID: 36864125
[TBL] [Abstract][Full Text] [Related]
3. A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate.
Akbulut O; Lengerli D; Saatci O; Duman E; Seker UOS; Isik A; Akyol A; Caliskan B; Banoglu E; Sahin O
Mol Cancer Ther; 2020 Jun; 19(6):1243-1254. PubMed ID: 32217742
[TBL] [Abstract][Full Text] [Related]
4. The centrosomal adaptor TACC3 and the microtubule polymerase chTOG interact via defined C-terminal subdomains in an Aurora-A kinase-independent manner.
Thakur HC; Singh M; Nagel-Steger L; Kremer J; Prumbaum D; Fansa EK; Ezzahoini H; Nouri K; Gremer L; Abts A; Schmitt L; Raunser S; Ahmadian MR; Piekorz RP
J Biol Chem; 2014 Jan; 289(1):74-88. PubMed ID: 24273164
[TBL] [Abstract][Full Text] [Related]
5. TACC3 protein regulates microtubule nucleation by affecting γ-tubulin ring complexes.
Singh P; Thomas GE; Gireesh KK; Manna TK
J Biol Chem; 2014 Nov; 289(46):31719-31735. PubMed ID: 25246530
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer.
Shi S; Guo D; Ye L; Li T; Fei Q; Lin M; Yu X; Jin K; Wu W
Cell Death Dis; 2023 Nov; 14(11):778. PubMed ID: 38012214
[TBL] [Abstract][Full Text] [Related]
7. A small compound targeting TACC3 revealed its different spatiotemporal contributions for spindle assembly in cancer cells.
Yao R; Kondoh Y; Natsume Y; Yamanaka H; Inoue M; Toki H; Takagi R; Shimizu T; Yamori T; Osada H; Noda T
Oncogene; 2014 Aug; 33(33):4242-52. PubMed ID: 24077290
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic Gene Fusion FGFR3-TACC3 Is Regulated by Tyrosine Phosphorylation.
Nelson KN; Meyer AN; Siari A; Campos AR; Motamedchaboki K; Donoghue DJ
Mol Cancer Res; 2016 May; 14(5):458-69. PubMed ID: 26869289
[TBL] [Abstract][Full Text] [Related]
9. FGFR3-TACC3 cancer gene fusions cause mitotic defects by removal of endogenous TACC3 from the mitotic spindle.
Sarkar S; Ryan EL; Royle SJ
Open Biol; 2017 Aug; 7(8):. PubMed ID: 28855393
[TBL] [Abstract][Full Text] [Related]
10. TACC3-ch-TOG interaction regulates spindle microtubule assembly by controlling centrosomal recruitment of γ-TuRC.
Rajeev R; Mukhopadhyay S; Bhagyanath S; Devu Priya MRS; Manna TK
Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36790370
[TBL] [Abstract][Full Text] [Related]
11. Suppression of centrosome protein TACC3 induces G1 arrest and cell death through activation of p38-p53-p21 stress signaling pathway.
Suhail TV; Singh P; Manna TK
Eur J Cell Biol; 2015 Feb; 94(2):90-100. PubMed ID: 25613365
[TBL] [Abstract][Full Text] [Related]
12. The transforming acidic coiled coil 3 protein is essential for spindle-dependent chromosome alignment and mitotic survival.
Schneider L; Essmann F; Kletke A; Rio P; Hanenberg H; Wetzel W; Schulze-Osthoff K; Nürnberg B; Piekorz RP
J Biol Chem; 2007 Oct; 282(40):29273-83. PubMed ID: 17675670
[TBL] [Abstract][Full Text] [Related]
13. Aurora A site specific TACC3 phosphorylation regulates astral microtubule assembly by stabilizing γ-tubulin ring complex.
Rajeev R; Singh P; Asmita A; Anand U; Manna TK
BMC Mol Cell Biol; 2019 Dec; 20(1):58. PubMed ID: 31823729
[TBL] [Abstract][Full Text] [Related]
14. TACC3-TSC2 maintains nuclear envelope structure and controls cell division.
Gómez-Baldó L; Schmidt S; Maxwell CA; Bonifaci N; Gabaldón T; Vidalain PO; Senapedis W; Kletke A; Rosing M; Barnekow A; Rottapel R; Capellá G; Vidal M; Astrinidis A; Piekorz RP; Pujana MA
Cell Cycle; 2010 Mar; 9(6):1143-55. PubMed ID: 20237422
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of transforming acidic coiled-coil-containing protein 3 (TACC3) reflects aggressiveness of primary central nervous system lymphomas.
Matsuda K; Sugita Y; Furuta T; Moritsubo M; Ohshima K; Morioka M; Takahashi K; Higaki K; Kakita A
Pathol Int; 2022 Sep; 72(9):437-443. PubMed ID: 35959857
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic driver FGFR3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.
Wang CG; Peiris MN; Meyer AN; Nelson KN; Donoghue DJ
Oncotarget; 2023 Feb; 14():133-145. PubMed ID: 36780330
[TBL] [Abstract][Full Text] [Related]
17. Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues.
Ulisse S; Baldini E; Toller M; Delcros JG; Guého A; Curcio F; De Antoni E; Giacomelli L; Ambesi-Impiombato FS; Bocchini S; D'Armiento M; Arlot-Bonnemains Y
Endocr Relat Cancer; 2007 Sep; 14(3):827-37. PubMed ID: 17914111
[TBL] [Abstract][Full Text] [Related]
18. Development of a degrader against oncogenic fusion protein FGFR3-TACC3.
Shibata N; Cho N; Koyama H; Naito M
Bioorg Med Chem Lett; 2022 Mar; 60():128584. PubMed ID: 35085722
[TBL] [Abstract][Full Text] [Related]
19. Recurrent FGFR3-TACC3 fusion gene in nasopharyngeal carcinoma.
Yuan L; Liu ZH; Lin ZR; Xu LH; Zhong Q; Zeng MS
Cancer Biol Ther; 2014; 15(12):1613-21. PubMed ID: 25535896
[TBL] [Abstract][Full Text] [Related]
20. TACC3 promotes epithelial-mesenchymal transition (EMT) through the activation of PI3K/Akt and ERK signaling pathways.
Ha GH; Park JS; Breuer EK
Cancer Lett; 2013 May; 332(1):63-73. PubMed ID: 23348690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
